CureVac N.V. (ETR:5CV)
Germany
· Delayed Price · Currency is EUR 3.138
-0.062 (-1.94%)
Feb 21, 2025, 5:35 PM CET
CureVac Market Cap
CureVac has a market cap or net worth of €708.26 million as of February 21, 2025. Its market cap has decreased by -4.25% in one year.
Market Cap
708.26M
Enterprise Value
540.66M
Revenue
65.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.14
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 708.26M, a decrease of -91.48%. That is a compound annual growth rate of -41.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 708.26M | -4.14% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 62.39B |
| Merck KGaA | 58.91B |
| Bayer Aktiengesellschaft | 21.66B |
| Fresenius SE & Co. KGaA | 20.55B |
| Sartorius Aktiengesellschaft | 15.02B |
| Fresenius Medical Care AG | 12.98B |
| Carl Zeiss Meditec AG | 4.78B |
| SCHOTT Pharma AG & Co. KGaA | 3.57B |